Medichem is a vertically integrated pharmaceutical company specializing in the development & manufacturing of APIs & FDFs.
01 1Medichem S.A.
02 1Centaur Pharmaceuticals Private Limited
01 1Loxapine Succinate
02 1loxapine succinate
01 1India
02 1Spain
Medichem is a vertically integrated pharmaceutical company specializing in the development & manufacturing of APIs & FDFs.
NDC Package Code : 53296-0017
Start Marketing Date : 2010-03-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (75kg/75kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 64330-112
Start Marketing Date : 2015-02-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Loxapine Succinate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Loxapine Succinate, including repackagers and relabelers. The FDA regulates Loxapine Succinate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Loxapine Succinate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Loxapine Succinate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Loxapine Succinate supplier is an individual or a company that provides Loxapine Succinate active pharmaceutical ingredient (API) or Loxapine Succinate finished formulations upon request. The Loxapine Succinate suppliers may include Loxapine Succinate API manufacturers, exporters, distributors and traders.
click here to find a list of Loxapine Succinate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Loxapine Succinate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Loxapine Succinate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Loxapine Succinate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Loxapine Succinate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Loxapine Succinate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Loxapine Succinate suppliers with NDC on PharmaCompass.
We have 2 companies offering Loxapine Succinate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
